Prognostic value of triglyceride-glucose index on predicting major adverse cardiovascular events in hypertensive patients: a systematic review and meta-analysis
- PMID: 40290417
- PMCID: PMC12032867
- DOI: 10.1016/j.ajpc.2025.100996
Prognostic value of triglyceride-glucose index on predicting major adverse cardiovascular events in hypertensive patients: a systematic review and meta-analysis
Abstract
Background: Triglyceride- glucose (TyG) index, a marker of insulin resistance, has been shown to be associated with the incidence of cardiometabolic diseases including hypertension. However, the prognostic role of TyG index is unknown. Hence, we aim to determine the association of TyG index with major adverse cardiovascular events (MACE) in hypertensive patients.
Methods: Systematic searching was conducted on 3 databases up till November 2024. We included studies with hypertensive patients despite their comorbidities. Outcome measured is MACE and its individual components. Random effect model meta-analysis is done to pool the results with similar reference point.
Results: Twenty observational studies with a total of 451,455 patients of 40 - 70 years old are included. Meta-analysis result shows that higher TyG index is associated with a statistically significant increased risk of MACE (HR 1.90, CI: 1.41 - 2.57, I2 88 %), myocardial infarction (HR 1.55, CI: 1.27 - 1.88, I2 0 %), stroke (HR 1.84, CI: 1.41 - 2.39, I2 62 %), all- cause mortality (HR 1.86, CI: 1.70 - 2.03, I2 0 %) and cardiovascular mortality (HR 1.08, CI: 1.04 - 1.11, I2 0 %). Subgroups of older and younger population, male and female gender, diabetic and non- diabetic population, and higher BMI patients retains the statistically significant risk of MACE (p < 0.05). U- shaped phenomena of TyG index is also demonstrated with the risk of all- cause mortality.
Conclusion: TyG index is a reliable prognostic marker of MACE in hypertensive patients and can be utilized in population despite their age, diabetic status, and gender.
Keywords: Glucose; Triglyceride; Triglyceride- glucose index; TyG.
© 2025 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Prognostic value of the triglyceride-glucose index for adverse cardiovascular outcomes in young adult hypertension.Clin Hypertens. 2024 Sep 1;30(1):25. doi: 10.1186/s40885-024-00274-9. Clin Hypertens. 2024. PMID: 39217344 Free PMC article.
-
The impact of triglyceride-glucose index on the prognosis of post-PCI patients-a meta-analysis.Front Cardiovasc Med. 2024 Jun 17;11:1396865. doi: 10.3389/fcvm.2024.1396865. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38952542 Free PMC article.
-
Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.Nutr Metab Cardiovasc Dis. 2021 Oct 28;31(11):3184-3192. doi: 10.1016/j.numecd.2021.07.027. Epub 2021 Aug 4. Nutr Metab Cardiovasc Dis. 2021. PMID: 34511291
-
Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2021 Dec 2;8:774781. doi: 10.3389/fcvm.2021.774781. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34926622 Free PMC article.
-
The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome - dose-response meta-analysis.Nutr Metab Cardiovasc Dis. 2021 Oct 28;31(11):3024-3030. doi: 10.1016/j.numecd.2021.08.026. Epub 2021 Aug 12. Nutr Metab Cardiovasc Dis. 2021. PMID: 34625361
Cited by
-
The novel triglyceride‒glucose-weighted adjusted waist index as a supplementary diagnostic tool for heart failure: evidence of improved reclassification beyond traditional TyG-related indices from a cross-sectional study.Cardiovasc Diabetol. 2025 Aug 12;24(1):329. doi: 10.1186/s12933-025-02896-1. Cardiovasc Diabetol. 2025. PMID: 40797254 Free PMC article.
-
Triglyceride glucose-weight-adjusted waist index as a cardiovascular mortality predictor: incremental value beyond the establishment of TyG-related indices.Cardiovasc Diabetol. 2025 Jul 30;24(1):306. doi: 10.1186/s12933-025-02873-8. Cardiovasc Diabetol. 2025. PMID: 40739633 Free PMC article.
-
Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank.Cardiovasc Diabetol. 2025 Jul 10;24(1):277. doi: 10.1186/s12933-025-02842-1. Cardiovasc Diabetol. 2025. PMID: 40640813 Free PMC article.
References
-
- Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet [Internet]. 2005;365(9455):217–223. https://www.sciencedirect.com/science/article/pii/S0140673605177411 Available from: - PubMed
-
- Wang F., Han L., Hu D. Fasting insulin, insulin resistance and risk of hypertension in the general population: a meta-analysis. Clin Chim Acta. 2017;464:57–63. Jan. - PubMed
LinkOut - more resources
Full Text Sources